Abstract
Background
The number of gastric bypass operations being performed is increasing rapidly due to good weight loss and alleviation of comorbidities in combination with low mortality and morbidity. Stomal ulcers are, however, a clinical problem after gastric bypass, giving patients discomfort, risk of bleeding, or even perforation. To measure the acidity in the proximal jejunum, we adopted the wireless pH-metry (BRAVO™ system) developed for evaluating reflux esophagitis.
Methods
Twenty-five patients (4 men; median age, 44 years; body mass index, 29.3) who had undergone Roux-en-Y gastric bypass (RYGBP) 4 years earlier were recruited. Twenty-one asymptomatic, non-proton pump inhibitor (PPI) users, and in addition, four symptomatic patients (ongoing or stopped PPI treatment) were studied. The wireless BRAVO™ capsule was positioned at the level of the gastrojejunal anastomosis under visual control with the endoscope. pH was registered for up to 48 h. Time with pH < 4 was calculated. Two patients were studied with two capsules.
Results
Of the 25 recruited patients, capsule placement was successful in all but two patients, and in three patients a constant neutral environment was seen before a premature loss of signal, indicating early loss of position. Thus, 20 successful measurements were made. The mean time of registration was 25.7 (range, 6.1–47.4) h (n = 20). In the 16 asymptomatic patients, median percentage of time with pH < 4 at the gastrojejunostomy was 10.5% (range, 0.4–37.7%). When dividing the registration time in day (06.00–22.00) and night (22.00–06.00), the median percentage of time with pH < 4 was 8.4 and 6.3, respectively (p = 0.08). The two double measurements gave similar results indicating consistency. No complications occurred.
Conclusions
Wireless pH measurements in the proximal jejunum after gastric bypass are feasible and safe. The acidity was significant (10.5% of the registration time) even in asymptomatic patients with small gastric pouches. The described method could be useful in evaluation of epigastralgia after gastric bypass and in appraisal of PPI treatment of stomal ulcer.
Similar content being viewed by others
References
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132:2087–2102
Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581–1586
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282:1523–1529
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555
Oguma Y, Sesso HD, Paffenbarger RS Jr, Lee IM (2005) Weight change and risk of developing type 2 diabetes. Obes Res 13:945–951
Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS (2005) A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352:1138–1145
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778
Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB (2003) Years of life lost due to obesity. JAMA 289:187–193
Katzmarzyk PT, Janssen I, Ardern CI (2003) Physical inactivity, excess adiposity and premature mortality. Obes Rev 4:257–290
Peeters A, Bonneux L, Barendregt J, Nusselder W (2003) Methods of estimating years of life lost due to obesity. JAMA 289:2941 author reply 2941–2942
Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752
Buchwald H, Oien DM (2009) Metabolic/bariatric surgery worldwide 2008. Obes Surg 19:1605–1611
Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761
Patel RA, Brolin RE, Gandhi A (2009) Revisional operations for marginal ulcer after Roux-en-Y gastric bypass. Surg Obes Relat Dis 5:317–322
Capella JF, Capella RF (1999) Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg 9:22–27 discussion 28
MacLean LD, Rhode BM, Nohr C, Katz S, McLean AP (1997) Stomal ulcer after gastric bypass. J Am Coll Surg 185:1–7
Smith CD, Herkes SB, Behrns KE, Fairbanks VF, Kelly KA, Sarr MG (1993) Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg 218:91–96
Hedberg J, Hedenstrom H, Nilsson S, Sundbom M, Gustavsson S (2005) Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg 15:1375–1378
Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ (2003) Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 98:740–749
Remes-Troche JM, Ibarra-Palomino J, Carmona-Sanchez RI, Valdovinos MA (2005) Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico. Am J Gastroenterol 100:2382–2386
Hess T, Hahn EG, Konturek PC (2009) BRAVO wireless 48 hour pH-metric system. Med Sci Monit 15:RA17–RA21
Ono S, Kato M, Ono Y, Asaka M (2007) New method for long-term monitoring of intragastric pH. World J Gastroenterol 13:6410–6413
Tuttle SG, Rufin F, Bettarello A (1961) The physiology of heartburn. Ann Intern Med 55:292–300
Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA, Albertucci M (1992) Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 87:1102–1111
Piper DW, Fenton BH (1965) pH stability and activity curves of pepsin with special reference to their clinical importance. Gut 6:506–508
Schriffin MJ (1940) Production of experimental jejunal ulcer. Proc Soc exp Biol 45:592–594
Siilin H, Wanders A, Gustavsson S, Sundbom M (2005) The proximal gastric pouch invariably contains acid-producing parietal cells in Roux-en-Y gastric bypass. Obes Surg 15:771–777
Sapala JA, Wood MH, Sapala MA, Schuhknecht MP, Flake TM Jr (2001) The micropouch gastric bypass: technical considerations in primary and revisionary operations. Obes Surg 11:3–17
Csendes A, Burgos AM, Altuve J, Bonacic S (2009) Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg 19:135–138
Acknowledgments
The authors thank Anna Ehrenborg, RN, for her invaluable help with recruiting patients and coordinating the study.
Disclosures
Drs. Hedberg, Hedenström, and Sundbom have no conflicts of interest or financial tie to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hedberg, J., Hedenström, H. & Sundbom, M. Wireless pH-metry at the gastrojejunostomy after Roux-en-Y gastric bypass: a novel use of the BRAVO™ system. Surg Endosc 25, 2302–2307 (2011). https://doi.org/10.1007/s00464-010-1553-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-010-1553-5